Neo Ivy Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-140,529
Closed -$3.5M 463
2025
Q4
$3.5M Buy
140,529
+101,383
+259% +$2.56M 0.55% 73
2025
Q3
$997K Sell
39,146
-82,138
-68% -$2.03M 0.24% 143
2025
Q2
$2.94M Buy
121,284
+43,542
+56% +$1.02M 0.94% 14
2025
Q1
$1.97M Sell
77,742
-62,715
-45% -$1.64M 0.63% 69
2024
Q4
$3.73M Buy
140,457
+63,289
+82% +$1.72M 0.75% 31
2024
Q3
$2.23M Buy
77,168
+71,500
+1,261% +$2.09M 0.72% 49
2024
Q2
$159K Buy
+5,668
New +$156K 0.03% 197
2023
Q4
Sell
-19,328
Closed -$641K 419
2023
Q3
$641K Buy
+19,328
New +$683K 0.28% 115
2022
Q3
Sell
-1,554
Closed -$81K 505
2022
Q2
$81K Sell
1,554
-6,126
-80% -$312K 0.22% 172
2022
Q1
$398K Buy
+7,680
New +$398K 0.36% 97
2021
Q4
Sell
-24,668
Closed -$807K 584
2021
Q3
$807K Buy
24,668
+5,893
+31% +$261K 0.93% 3
2021
Q2
$735K Buy
18,775
+14,045
+297% +$546K 0.74% 31
2021
Q1
$171K Buy
+4,730
New +$168K 0.19% 177
2020
Q4
Sell
-19,156
Closed -$667K 539
2020
Q3
$667K Sell
19,156
-6,844
-26% -$240K 0.67% 21
2020
Q2
$807K Buy
+26,000
New +$883K 0.93% 3
2019
Q2
Sell
-5,050
Closed -$203K 377
2019
Q1
$203K Buy
+5,050
New +$202K 0.12% 199

Other funds holding PFE

Neo Ivy Capital Management's PFE Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 140,529 shares — an estimated $3.5M sold.

Neo Ivy Capital Management first reported a position in PFE in Q1 2019 and held it in 16 quarters. The position peaked at $3.73M in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Neo Ivy Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 140,529 Pfizer shares in Q1 2026, an estimated $3.5M.
  • Neo Ivy Capital Management first reported a position in Pfizer in Q1 2019 and held it in 16 quarters.
  • Neo Ivy Capital Management's Pfizer position peaked at $3.73M in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.